197 related articles for article (PubMed ID: 26354532)
1. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
[TBL] [Abstract][Full Text] [Related]
3. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
McCullough ML; Rodriguez C; Diver WR; Feigelson HS; Stevens VL; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2898-904. PubMed ID: 16365007
[TBL] [Abstract][Full Text] [Related]
4. Intake of dairy products, calcium, and vitamin d and risk of breast cancer.
Shin MH; Holmes MD; Hankinson SE; Wu K; Colditz GA; Willett WC
J Natl Cancer Inst; 2002 Sep; 94(17):1301-11. PubMed ID: 12208895
[TBL] [Abstract][Full Text] [Related]
5. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
6. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
7. Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Abbas S; Linseisen J; Rohrmann S; Chang-Claude J; Peeters PH; Engel P; Brustad M; Lund E; Skeie G; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Fagherazzi G; Kaaks R; Boeing H; Buijsse B; Adarakis G; Ouranos V; Trichopoulou A; Masala G; Krogh V; Mattiello A; Tumino R; Sacerdote C; Buckland G; Suárez MV; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Manjer J; Wirfält E; Lenner P; Sund M; Bueno-de-Mesquita HB; van Duijnhoven FJ; Khaw KT; Wareham N; Key TJ; Fedirko V; Romieu I; Gallo V; Norat T; Wark PA; Riboli E
Nutr Cancer; 2013; 65(2):178-87. PubMed ID: 23441605
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
9. Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Am J Clin Nutr; 2016 Jul; 104(1):228-34. PubMed ID: 27194303
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
[TBL] [Abstract][Full Text] [Related]
12. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.
Fournier A; Mesrine S; Dossus L; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
Breast Cancer Res Treat; 2014 Jun; 145(2):535-43. PubMed ID: 24781971
[TBL] [Abstract][Full Text] [Related]
13. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
14. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan.
Kawase T; Matsuo K; Suzuki T; Hirose K; Hosono S; Watanabe M; Inagaki M; Iwata H; Tanaka H; Tajima K
Cancer Sci; 2010 May; 101(5):1234-40. PubMed ID: 20151981
[TBL] [Abstract][Full Text] [Related]
15. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study.
Touillaud M; Gelot A; Mesrine S; Bennetau-Pelissero C; Clavel-Chapelon F; Arveux P; Bonnet F; Gunter M; Boutron-Ruault MC; Fournier A
Am J Clin Nutr; 2019 Mar; 109(3):597-605. PubMed ID: 30831601
[TBL] [Abstract][Full Text] [Related]
16. Calcium plus vitamin D supplementation and the risk of breast cancer.
Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA;
J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women.
Anderson LN; Cotterchio M; Vieth R; Knight JA
Am J Clin Nutr; 2010 Jun; 91(6):1699-707. PubMed ID: 20392891
[TBL] [Abstract][Full Text] [Related]
18. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
Cauley JA; Chlebowski RT; Wactawski-Wende J; Robbins JA; Rodabough RJ; Chen Z; Johnson KC; O'Sullivan MJ; Jackson RD; Manson JE
J Womens Health (Larchmt); 2013 Nov; 22(11):915-29. PubMed ID: 24131320
[TBL] [Abstract][Full Text] [Related]
19. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
[TBL] [Abstract][Full Text] [Related]
20. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium.
Gaudet MM; Barrdahl M; Lindström S; Travis RC; Auer PL; Buring JE; Chanock SJ; Eliassen AH; Gapstur SM; Giles GG; Gunter M; Haiman C; Hunter DJ; Joshi AD; Kaaks R; Khaw KT; Lee IM; Le Marchand L; Milne RL; Peeters PH; Sund M; Tamimi R; Trichopoulou A; Weiderpass E; Yang XR; Prentice RL; Feigelson HS; Canzian F; Kraft P
Breast Cancer Res Treat; 2016 Feb; 155(3):531-40. PubMed ID: 26802016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
